Boai NKY Medical Holdings Partners with HuaDao Biopharma for CAR-T Therapy Incubator
Boai NKY Medical Holdings Ltd (SHE: 300109), a Chinese biotech company, has announced a strategic...
China’s NHSA Unveils Measures to Secure Volume-Based Procurement Supply
The National Healthcare Security Administration (NHSA) has issued a notification outlining key measures to ensure...
BMS’s Mavacamten Used to Treat First Patient with Hypertrophic Cardiomyopathy in Hainan
Bristol-Myers Squibb (BMS; NYSE: BMY) has announced that the first patient with obstructive hypertrophic cardiomyopathy...
Shanghai’s EnjoSim Secures Tens of Millions in Pre-Series A Funding for Expansion
EnjoSim, a Shanghai-based developer of microbiologic self-administration systems, has reportedly secured tens of millions of...
Pfizer Eyes Further ADC Expansion, Potentially in China, Says Chief Oncology Officer
Dr. Chris Boshoff, Pfizer (NYSE: PFE)’s recently appointed chief oncology officer, disclosed in an interview...
CARsgen Therapeutics Gets NMPA Approval for CAR-T Therapy CT011 in Hepatocellular Carcinoma
China-based CARsgen Therapeutics Holdings Ltd (HKG: 2171) has announced that it has received approval from...
Simcere Pharmaceutical Group Gets NMPA Green Light for USP1 Inhibitor SIM0501
Simcere Pharmaceutical Group (HKG: 2096) has announced that it has received clinical trial approval from...
Ant Insurance Reports 23% Surge in Health Insurance Payouts, Processing 4.69 Million Claims in 2023
Ant Insurance, a platform integrated within Alibaba’s Alipay app, reported a 23% year-on-year increase in...
Myrobalan Therapeutics Secures $24 Million in Series A Funding with Strong Chinese Investor Support
Myrobalan Therapeutics, a Massachusetts-based biotech firm, has successfully completed a $24 million Series A funding...
Huadong Medicine’s Relmapirazin Approval Filing Accepted by NMPA for GFR Measurement
Huadong Medicine Co., Ltd (SHE: 000963), based in China, has announced that its market approval...
Lepu Medical Secures NMPA Approval for Innovative Coronary Intravascular Impact Waveguide Tube
Lepu Medical Technology (Beijing) Co., Ltd (SHE: 300003), a China-based provider of cardiovascular disease solutions,...
CORXEL Secures Licensing Rights for Biogen’s BIIB131 in Stroke Treatment
Shanghai-based CORXEL, formerly known as Ji Xing Pharmaceuticals, supported by RTW Investments, has secured a...
Boehringer Ingelheim Expands Greek Facility to Boost Production of Jardiance and Other Medications
Boehringer Ingelheim (BI), headquartered in Germany, has commenced the expansion of its manufacturing facility in...
Fosun Kite and Medi Cover Launch First Value-Based Payment Plan for Lymphoma Treatment
Fosun Kite and Medi Cover, a health management and patient service platform under Sinopharm (HKG:...
Novo Nordisk’s IcoSema Shows Promise in Late-Stage Trial for Type 2 Diabetes Management
Danish pharmaceutical giant Novo Nordisk (CPH: NOVO-B) has announced positive results from a late-stage trial...
AbbVie’s Lutikizumab Advances to Phase III for Hidradenitis Suppurativa After Positive Mid-Stage Results
AbbVie (NYSE: ABBV) has announced the progression of lutikizumab to Phase III clinical trials following...
Changchun High & New Technology to Transfer 7.42% Stake to Ex-Wife in Divorce Settlement
Changchun High & New Technology Industries (Group) Inc., (SHE: 000661) has announced plans to transfer...
Bio-Thera Solutions Receives NMPA Approval for Combined Phase Ib/II Study of BAT7104 and BAT4706
Bio-Thera Solutions Ltd (SHA: 688177), a Chinese biopharmaceutical company, has announced that it has received...
Eisai’s Lemborexant Sleep Aid Lemborexant Filed for NMPA Approval in China
The China Center for Drug Evaluation (CDE) website has indicated that Japan-based Eisai (TYO: 4523)...
Astellas Pharma Appoints Zhao Ping as Chairman of China Operations
Effective January 15, 2024, Astellas Pharma (TYO: 4503), a leading Japanese pharmaceutical company, has appointed...